Location History:
- Clovis, NM (US) (1976 - 1978)
- Oxford, OH (US) (1988 - 1990)
Company Filing History:
1 out of 4 
1 out of 9 
5 out of 832,812 Years Active: 1976-1990
Title: The Innovations of Charles C. Griffin: A Journey Through His Patents
Introduction: Charles C. Griffin, an accomplished inventor based in Oxford, OH, has made significant contributions to the field of biomedical innovations. With a total of seven patents to his name, Griffin's work predominantly focuses on the development of low molecular weight heparin derivatives, which have far-reaching implications for anticoagulant therapies.
Latest Patents: Among Griffin's notable inventions are two recent patents that stand out for their potential to revolutionize anticoagulant treatments. The first, titled "Low molecular weight heparin derivatives having improved anti-Xa," unveils ester derivatives of low molecular weight heparin. These innovative derivatives showcase enhanced Anti-Xa activity compared to traditional forms, significantly impacting global anticlotting efficacy. The second patent, "Low molecular weight heparin derivatives with improved permeability," describes novel low molecular weight heparin derivatives that incorporate hydrophobic groups. These derivatives not only exhibit improved permeability but also demonstrate anticoagulant activity and enhanced solubility in organic solvents, paving the way for more effective therapeutic applications.
Career Highlights: Throughout his career, Charles C. Griffin has worked with various companies, notably Hepar Industries, Inc. His dedication to research and innovation has not only led to groundbreaking patents but has also positioned him as a respected figure in the biomedical patent landscape.
Collaborations: Collaborating with distinguished professionals has also been a hallmark of Griffin's career. He has worked alongside colleagues such as Kevin M. Foley and Eduardo Amaya, contributing to a collaborative atmosphere that fosters innovative ideas and advancements in their field.
Conclusion: In summary, Charles C. Griffin stands out as a prominent inventor, whose work on low molecular weight heparin derivatives is shaping the future of anticoagulant therapies. His patents reflect a deep commitment to innovation and collaboration, making him a key player in advancing biomedical research. Through his inventions, Griffin continues to impact the medical community and improve patient care worldwide.